课题基金 / 基金详情

Sensitivity of multiple myeloma cells to mTOR inhibitors

Sensitivity of multiple myeloma cells to mTOR inhibitors
多发性骨髓瘤细胞对 mTOR 抑制剂的敏感性
批准号:
8484360
负责人:
ALAN K LICHTENSTEIN
金额:
$17.32万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2017-04-30

项目摘要

项目成果

ALAN K LICHTENSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 项目总结/ASBTRACT本项目的主要目的是为多发性骨髓瘤患者中TORC 2多蛋白复合物的未来治疗靶向提供依据。目的包括研究mTOR激酶抑制剂对骨髓瘤细胞系和患者原代细胞标本的体外和体内小鼠模型,确定关键的TORC 2底物,这些底物是抑制的关键靶点,并测试DEPTOR蛋白表达在调节骨髓瘤细胞对TORC 2抑制剂的敏感性中的作用。将研究骨髓瘤细胞的活力与死亡以及它们在体外粘附和迁移的能力。还将尝试鉴定和开发防止TORC 2复合物内的蛋白质-蛋白质相互作用的新型化合物。
英文摘要
DESCRIPTION (provided by applicant): PROJECT SUMMARY/ASBTRACT The main objective of this project is to provide a rationale for future therapeutic targeting of the TORC2 multiprotein complex in patients with multiple myeloma. The aims include studying mTOR kinase inhibitors against myeloma cell lines and patient primary cell specimens in vitro and in murine models in vivo, identifying the key TORC2 substrates that are the critical targets for inhibition and testing the role of DEPTOR protein expression in regulating the sensitivity of myeloma cells to TORC2 inhibitors. The viability versus death of myeloma cells as well as their ability to adhere and migrate in vitro will be studied. The identification and development of novel compounds which prevent protein-protein interactions within the TORC2 complex will also be attempted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
Targeting DEPTOR in multiple myeloma
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
Targeting DEPTOR in multiple myeloma
海外基金